Mira Pharmaceuticals (MIRA) EBITDA (2022 - 2026)
Mira Pharmaceuticals (MIRA) EBITDA from Mar 31, 2022 to Mar 31, 2026. The TTM Mira Pharmaceuticals (MIRA) EBITDA is -$9.79M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Mira Pharmaceuticals (MIRA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +74.20% |
| 3 Years TTM | +12.31% |
| All Time TTM | +12.31% |
Annual EBITDA change of Mira Pharmaceuticals (MIRA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$1.15M | -88.98% |
| 2025 | -$10M | +30.17% |
| 2024 | -$8.02M | -5.98% |
| 2023 | -$8.53M | +20.99% |
| 2022 | -$7.05M | N/A |